Annual Drug Patent Expirations for VYNDAMAX
Vyndamax is a drug marketed by Foldrx Pharms and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
Drug patent litigation for VYNDAMAX.
This drug has fifty-four patent family members in twenty-eight countries.
The generic ingredient in VYNDAMAX is tafamidis. One supplier is listed for this compound. Additional details are available on the tafamidis profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
